River Vision Overview
- Founded
-
2011
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$475M
River Vision General Information
Description
Developer of protein therapies designed for the treatment of Graves' Orbitopathy. The company's protein therapies include a human monoclonal antibody Teprotumumab, is a fully human mAb inhibitor of insulin-like growth factor type 1 receptor (IGF-1R) used for the treatment of active phase Graves Orbitopathy (GO), enabling users treat patients with tissue proliferation and excess production of extracellular matrix.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Office
- One Rockefeller Plaza
- Suite 1204
- New York, NY 10020
- United States
+1 (212) 000-0000
River Vision Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 08-May-2017 | $475M | 000.00 | 00000 | Completed | Product Development |
| 5. Early Stage VC (Series B) | 01-May-2017 | 000.00 | Completed | Generating Revenue | ||
| 4. Early Stage VC (Series A) | 21-Jan-2016 | 000 | 000.00 | 000.00 | Completed | Startup |
| 3. Early Stage VC (Series A) | 02-Feb-2015 | 00.00 | 000.00 | 000.00 | Completed | Startup |
| 2. Early Stage VC (Series A) | 07-Jan-2014 | $6M | $17M | 000.00 | Completed | Startup |
| 1. Early Stage VC (Series A) | 10-Dec-2012 | $11M | $11M | 000.00 | Completed | Startup |
River Vision Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00.00 | 00 | 00 | 00 | 00 | 00.000 |
River Vision Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Lundbeckfonden BioCapital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Narrow River Management | Limited Partner | Minority | 000 0000 | 000000 0 | |
| SR One | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Vivo Capital | Venture Capital | Minority | 000 0000 | 000000 0 |